Development of Biosimilar Aflibercept SDZ-AFL.

Dodeller F, Alliger P, Heyn J, Urosevic D, Allmannsberger L, Wersig C, Silva R

Open source

DOI
10.1016/j.curtheres.2025.100812
Published
2025
Container
Current therapeutic research, clinical and experimental
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.curtheres.2025.100812,
  title = {Development of Biosimilar Aflibercept SDZ-AFL.},
  author = {Dodeller F and Alliger P and Heyn J and Urosevic D and Allmannsberger L and Wersig C and Silva R},
  year = {2025},
  journal = {Current therapeutic research, clinical and experimental},
  doi = {10.1016/j.curtheres.2025.100812},
  url = {https://doi.org/10.1016/j.curtheres.2025.100812}
}

RIS

TY  - JOUR
TI  - Development of Biosimilar Aflibercept SDZ-AFL.
AU  - Dodeller F
AU  - Alliger P
AU  - Heyn J
AU  - Urosevic D
AU  - Allmannsberger L
AU  - Wersig C
AU  - Silva R
PY  - 2025
JO  - Current therapeutic research, clinical and experimental
DO  - 10.1016/j.curtheres.2025.100812
UR  - https://doi.org/10.1016/j.curtheres.2025.100812
ER  - 

APA

F, D., P, A., J, H., D, U., L, A., C, W., & R, S. (2025). Development of Biosimilar Aflibercept SDZ-AFL.. Current therapeutic research, clinical and experimental. https://doi.org/10.1016/j.curtheres.2025.100812

Source records